Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1986 2
1988 2
1990 2
1992 1
1993 2
1994 1
1995 1
1996 1
1998 1
1999 1
2006 1
2011 1
2012 2
2016 1
2018 1
2020 2
2021 1
2022 3
2023 5
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Antimicrobial photosensitive reactions.
Vassileva SG, Mateev G, Parish LC. Vassileva SG, et al. Among authors: mateev g. Arch Intern Med. 1998 Oct 12;158(18):1993-2000. doi: 10.1001/archinte.158.18.1993. Arch Intern Med. 1998. PMID: 9778198 Review.
Burn-induced bullous pemphigoid.
Vassileva S, Mateev G, Balabanova M, Tsankov N. Vassileva S, et al. Among authors: mateev g. J Am Acad Dermatol. 1994 Jun;30(6):1027-8. doi: 10.1016/s0190-9622(09)80149-7. J Am Acad Dermatol. 1994. PMID: 8188869 No abstract available.
Burn-induced bullous pemphigoid.
Vassileva S, Mateev G, Tsankov N. Vassileva S, et al. Among authors: mateev g. Int J Dermatol. 1995 Jul;34(7):516-7. doi: 10.1111/j.1365-4362.1995.tb00632.x. Int J Dermatol. 1995. PMID: 7591423 Review. No abstract available.
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ; ARROYO Study Investigators. Altrichter S, et al. Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067. Br J Dermatol. 2024. PMID: 38367194 Clinical Trial.
Is the BCG vaccine a useful tool against COVID-19?
Zhelezova G, Mateeva V, Mateev G. Zhelezova G, et al. Among authors: mateev g. Clin Dermatol. 2021 Jan-Feb;39(1):98-103. doi: 10.1016/j.clindermatol.2020.12.018. Epub 2020 Dec 16. Clin Dermatol. 2021. PMID: 33972060 Free PMC article.
34 results